華檢醫療(01931.HK)擬動用最多8.8億元購入ETH 首批買入5,190枚ETH涉近1.5億元
華檢醫療(01931.HK)宣布,為推進「全球增強版以太坊(ETH)金庫」戰略的快速落地,經董事會決議批准,將動用最多8.8億元於公開市場購買以太坊(ETH)作為儲備資產,將通過自有資金及透過募集資金活動籌集的資金來加大購買額度。
公司通過香港持牌虛擬資產交易所HashKey Exchange完成首批ETH合規購買,並計劃通過定投式加倉策略持續增持,目標成為ETH儲備規模領先的上市公司。截至今日(8日),首批合共買入5,190枚ETH,每枚平均價格為28,798.21元,折合約3,661美元,總交易對價1.49億元。
華檢醫療指,近日亦與HashKey Group簽訂全球戰略合作框架協議,雙方將攜手推進集團全球增強版以太坊(ETH)金庫戰略的落地實施,並為雙方的全球客戶提供更加高效、安全、合規的數字資產服務。
另外,華檢醫療早前公布啟動「IVDNewCo Exchange」-全球首個聚焦醫療創新藥NewCo高科技資產的RWA交易所生態及「 IVDD」穩定幣計劃,目前已正式將此「NewCo +RWA」Web3交易所命名為「ivd.xyz」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.